NO995800L - Anvendelse av oligosakkarid for forhindring av blodkoagulering i ekstrakorporeale blodkretser - Google Patents

Anvendelse av oligosakkarid for forhindring av blodkoagulering i ekstrakorporeale blodkretser

Info

Publication number
NO995800L
NO995800L NO995800A NO995800A NO995800L NO 995800 L NO995800 L NO 995800L NO 995800 A NO995800 A NO 995800A NO 995800 A NO995800 A NO 995800A NO 995800 L NO995800 L NO 995800L
Authority
NO
Norway
Prior art keywords
oligosaccharide
circuits
prevent
extracorporeal
extracorporeal blood
Prior art date
Application number
NO995800A
Other languages
English (en)
Other versions
NO325142B1 (no
NO995800D0 (no
Inventor
Jean-Marc Herbert
Jacobus Christianus J Stiekema
Original Assignee
Akzo Nobel Nv
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sanofi Synthelabo filed Critical Akzo Nobel Nv
Publication of NO995800D0 publication Critical patent/NO995800D0/no
Publication of NO995800L publication Critical patent/NO995800L/no
Publication of NO325142B1 publication Critical patent/NO325142B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
NO19995800A 1997-05-27 1999-11-26 Anvendelse av oligosakkarid for fremstilling av et medikament for forhindring av blodkoagulering i ekstra korporlige blodkretser NO325142B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201586 1997-05-27
PCT/EP1998/003174 WO1998053829A1 (en) 1997-05-27 1998-05-22 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits

Publications (3)

Publication Number Publication Date
NO995800D0 NO995800D0 (no) 1999-11-26
NO995800L true NO995800L (no) 1999-11-26
NO325142B1 NO325142B1 (no) 2008-02-11

Family

ID=8228366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995800A NO325142B1 (no) 1997-05-27 1999-11-26 Anvendelse av oligosakkarid for fremstilling av et medikament for forhindring av blodkoagulering i ekstra korporlige blodkretser

Country Status (12)

Country Link
US (3) US6391339B1 (no)
EP (2) EP0984785B1 (no)
JP (2) JP2002503270A (no)
AT (1) ATE307596T1 (no)
AU (1) AU8211398A (no)
BR (1) BR9809478A (no)
CA (1) CA2289522A1 (no)
DE (1) DE69832066T2 (no)
DK (1) DK0984785T3 (no)
ES (1) ES2251090T3 (no)
NO (1) NO325142B1 (no)
WO (1) WO1998053829A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE307596T1 (de) * 1997-05-27 2005-11-15 Sanofi Aventis Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe
FR2804328B1 (fr) 2000-01-27 2002-03-15 Hospal Ind Membrane semi-permeable non thrombogene et procede de fabrication
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および／または線溶系酵素阻害剤との組み合わせからなる医薬
CA2782311C (en) * 2009-12-01 2017-06-27 Robert S. Ward Method for removing cytokines from blood with surface immobilized polysaccharides
ES2647577T3 (es) 2012-06-13 2017-12-22 Exthera Medical Corporation Uso de heparina y carbohidratos para tratar el cáncer
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
CA2946294C (en) 2014-04-24 2023-03-21 Exthera Medical Corporation Method for removing bacteria from blood using high flow rate
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
CN113825517A (zh) 2019-05-16 2021-12-21 艾克塞拉医疗公司 调节内皮糖萼结构的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002A (en) * 1841-03-12 Tor and planter for plowing
DE3008993A1 (de) * 1980-03-08 1981-10-01 Röhm Pharma GmbH, 6100 Darmstadt Pharmazeutische zubereitungen
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
US4818816A (en) * 1981-04-28 1989-04-04 Choay, S.A. Process for the organic synthesis of oligosaccharides and derivatives thereof
US4987223A (en) * 1981-12-23 1991-01-22 Choay S.A. Derivatives of the uronic acid
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
US4801583A (en) * 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
JPS63218691A (ja) * 1987-03-09 1988-09-12 Rikagaku Kenkyusho 新規な５糖類化合物及びその製造法並びに抗凝血及び抗血栓剤
EP0300099A1 (en) * 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US5252213A (en) * 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
WO1993005825A1 (en) * 1991-09-20 1993-04-01 Baxter International Inc. Processes for reducing the thrombogenicity of biomaterials
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US6391369B1 (en) * 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
IL120722A (en) * 1996-05-08 1999-07-14 Akzo Nobel Nv Polysulfated tetrasaccharide derivatives and pharmaceutical compositions containing them
ATE307596T1 (de) * 1997-05-27 2005-11-15 Sanofi Aventis Verwendung eines oligosaccharids zur vorbeugung von blutgerinnung in extrakorporale kreisläufe

Also Published As

Publication number Publication date
JP2010013455A (ja) 2010-01-21
NO325142B1 (no) 2008-02-11
AU8211398A (en) 1998-12-30
DE69832066D1 (de) 2005-12-01
ES2251090T3 (es) 2006-04-16
EP1593380A3 (en) 2008-06-11
NO995800D0 (no) 1999-11-26
CA2289522A1 (en) 1998-12-03
DK0984785T3 (da) 2006-01-30
BR9809478A (pt) 2000-06-20
US20070197637A1 (en) 2007-08-23
WO1998053829A1 (en) 1998-12-03
EP0984785A1 (en) 2000-03-15
US20020040012A1 (en) 2002-04-04
US6391339B1 (en) 2002-05-21
EP1593380A2 (en) 2005-11-09
DE69832066T2 (de) 2006-07-13
JP2002503270A (ja) 2002-01-29
ATE307596T1 (de) 2005-11-15
EP0984785B1 (en) 2005-10-26

Similar Documents

Publication Publication Date Title
DK0976722T3 (da) Benzamidin-derivater
TR200002904T2 (tr) Amidin bileşikleri
DE60120761D1 (de) Hämodiafiltration/hämofiltrations-patronen
FI904450A0 (fi) Nya peptidas- och isomerasinhibitorer.
IT1316986B1 (it) Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
DE69103844D1 (de) Einstufiger Venenkatheter.
NO986051L (no) Anvendelsen av topiramat eller derivater derav for fremstilling av et medikament for behandling av manisk depressive, bipolare forstyrrelser
BR9916678A (pt) Inibidores de trombina
DE69206465D1 (de) Peritonealdialyse-Katheter.
MX9804597A (es) Derivados de bencimidazol sustituidos por naftilo como anticoagulantes.
NO995800L (no) Anvendelse av oligosakkarid for forhindring av blodkoagulering i ekstrakorporeale blodkretser
EA200100025A1 (ru) Соединения пиразинона, фармацевтическая композиция (варианты) и лекарственная форма, способ ингибирования протеазы, способ снижения тромбообразующей способности поверхности, способ лечения нарушенного протеолиза и тромбоза, связанного с различными заболеваниями, способ снижения свертывания крови и способ определения тромбина у млекопитающего
WO2001037894A3 (en) Fluid replacement systems and methods for use in hemofiltration
DE68922887D1 (de) Zusammengesetzter Gefässkatheter.
DE60122750D1 (de) Amidine-inhibitoren der serine-proteasen
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
DE60025698D1 (de) Neue dialysemethode
FI952593A0 (fi) Hyytymistä estävä aine
DE69118056D1 (de) Anticoagulatorische Zusammensetzung aus LACI und sulfatierten Polysacchariden
ATE397424T1 (de) Implantierbare intraluminale vorrichtung
DK0811376T3 (da) Anvendelse af alkanoyl-L-carnitiner til fremstilling af et lægemiddel til behandling af inflammatoriske tarmsygdomme
DE10084241D2 (de) Heparin mit mittlerer Molmasse
FI900097A0 (fi) Foerfarande foer bestaemning av den fibrin upploesande totalaktiviteten i plasma.
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung

Legal Events

Date Code Title Description
MK1K Patent expired